Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)
SEK 50.0
(4.17%)
SEK 50.0
(4.17%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -9.95 SEK | -71.55% |
| 2022 | -5.80 SEK | -43.56% |
| 2021 | -4.04 SEK | 37.27% |
| 2020 | -6.44 SEK | -53.7% |
| 2019 | -4.19 SEK | -11.44% |
| 2018 | -3.76 SEK | 41.8% |
| 2017 | -6.46 SEK | 14.32% |
| 2016 | -7.54 SEK | 25.05% |
| 2015 | -10.06 SEK | -398.02% |
| 2014 | -2.02 SEK | 0.0% |
| 2013 | - SEK | 100.0% |
| 2012 | -0.00 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -3.17 SEK | -53.88% |
| 2024 Q1 | -2.06 SEK | 32.24% |
| 2023 Q2 | -2.57 SEK | -28.5% |
| 2023 FY | - SEK | -71.55% |
| 2023 Q4 | -3.04 SEK | -31.6% |
| 2023 Q3 | -2.31 SEK | 10.12% |
| 2023 Q1 | -2.00 SEK | 43.18% |
| 2022 Q2 | 0.15 SEK | 108.72% |
| 2022 Q4 | -3.52 SEK | -402.86% |
| 2022 FY | - SEK | -43.56% |
| 2022 Q1 | -1.72 SEK | -19.44% |
| 2022 Q3 | -0.70 SEK | -566.67% |
| 2021 Q4 | -1.44 SEK | -27592.31% |
| 2021 FY | - SEK | 37.27% |
| 2021 Q1 | 0.04 SEK | 101.7% |
| 2021 Q3 | -0.01 SEK | 99.8% |
| 2021 Q2 | -2.60 SEK | -6567.66% |
| 2020 Q1 | 0.10 SEK | 104.08% |
| 2020 Q3 | -1.66 SEK | 33.33% |
| 2020 Q4 | -2.37 SEK | -42.77% |
| 2020 FY | - SEK | -53.7% |
| 2020 Q2 | -2.49 SEK | -2590.0% |
| 2019 Q4 | -2.45 SEK | -160.64% |
| 2019 Q3 | -0.94 SEK | -40.3% |
| 2019 Q2 | -0.67 SEK | -996.56% |
| 2019 FY | - SEK | -11.44% |
| 2019 Q1 | -0.06 SEK | 97.16% |
| 2018 Q3 | -0.71 SEK | -1299.32% |
| 2018 Q1 | -0.96 SEK | 37.66% |
| 2018 FY | - SEK | 41.8% |
| 2018 Q4 | -2.15 SEK | -202.82% |
| 2018 Q2 | 0.06 SEK | 106.17% |
| 2017 Q2 | -2.51 SEK | -60.9% |
| 2017 Q1 | -1.56 SEK | 32.17% |
| 2017 FY | - SEK | 14.32% |
| 2017 Q3 | -0.78 SEK | 68.92% |
| 2017 Q4 | -1.54 SEK | -97.44% |
| 2016 Q4 | -2.30 SEK | -84.0% |
| 2016 Q2 | -2.51 SEK | 10.99% |
| 2016 Q1 | -2.82 SEK | -206.02% |
| 2016 FY | - SEK | 25.05% |
| 2016 Q3 | -1.25 SEK | 50.2% |
| 2015 Q3 | 2.66 SEK | 198.52% |
| 2015 Q1 | -2.70 SEK | 0.0% |
| 2015 FY | - SEK | -398.02% |
| 2015 Q4 | 2.66 SEK | 0.0% |
| 2015 Q2 | -2.70 SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2013 FY | - SEK | 100.0% |
| 2012 FY | - SEK | 0.0% |